Cochrane Review Group
Airways
216 systematic reviews in Airways ask 2,325 questions. 10.7% have no studies to answer them, 11.9% rest on very low certainty evidence and 40.5% reach moderate or high certainty.
Reviews
216
Questions
2,325
current versions
No studies
10.7%
Moderate or high
40.5%
No studies 249 · 10.7%Ungraded 107 · 4.6%Very low 276 · 11.9%Low 751 · 32.3%Moderate 718 · 30.9%High 224 · 9.6%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Symptoms of anxiety · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 5 studies · 431 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Symptoms of depression · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 2 studies · 166 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Medical contacts Assessed as hospital admissions, ED presentations or asthma‐related urgent care visits. · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 5 studies · 636 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Asthma attacks · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 3 studies · 129 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Asthma symptoms · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 11 studies · 720 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Medication use · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 8 studies · 822 participants | Very low |
Psychological interventions vs usual care, no intervention, or treatment with no psychological component Quality of life · adolescents with asthma Psychological interventions for asthma in children and adolescents (2024) · Cochrane | no estimate extracted | 6 studies · 653 participants | Very low |
Triple therapy vs LABA/LAMA combination Outcomes (weighted · people with stable COPD Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic… (2023) · Cochrane | no estimate extracted | NR | No studies |
Carbonic anhydrase inhibitors vs inactive control cAHI · adults with central sleep apnoea associated with heart failure Pharmacological treatment for central sleep apnoea in adults (2023) · Cochrane | no estimate extracted | 1 study · 12 participants | Very low |
Anxiolytics vs inactive control Cardiovascular mortality · adults with central sleep apnoea associated with heart failure Pharmacological treatment for central sleep apnoea in adults (2023) · Cochrane | no estimate extracted | NR | No studies |
Anxiolytics vs inactive control Serious adverse events · adults with central sleep apnoea associated with heart failure Pharmacological treatment for central sleep apnoea in adults (2023) · Cochrane | no estimate extracted | NR | No studies |
Anxiolytics vs inactive control Quality of sleep · adults with central sleep apnoea associated with heart failure Pharmacological treatment for central sleep apnoea in adults (2023) · Cochrane | no estimate extracted | NR | No studies |
Reviews 216
Different oral corticosteroid regimens for acute asthma
CochraneSoF table
24 questions
Cognitive behavioural therapy (CBT) for adults and adolescents with asthma
CochraneSoF table
7 questions
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
CochraneSoF table
5 questions
Non‐invasive positive pressure ventilation for acute asthma in children
CochraneSoF table
4 questions
Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults
CochraneSoF table
4 questions
Pulmonary rehabilitation for chronic obstructive pulmonary disease
CochraneSoF table
5 questions
Addition of long‐acting beta₂‐agonists to inhaled corticosteroids for chronic asthma in children
CochraneSoF table
14 questions
Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children
CochraneSoF table
10 questions
Airway clearance techniques for bronchiectasis
CochraneSoF table
7 questions
Long‐acting beta₂‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta₂‐agonist alone for chronic obstructive pulmonary disease
CochraneSoF table
12 questions
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
CochraneSoF table
7 questions
Calcium channel blockers for pulmonary arterial hypertension
CochraneSoF table
2 questions
Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive pulmonary disease
CochraneSoF table
12 questions
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
CochraneSoF table
13 questions
Effects of opioid, hypnotic and sedating medications on sleep‐disordered breathing in adults with obstructive sleep apnoea
CochraneSoF table
3 questions
Stopping long‐acting beta₂‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
CochraneSoF table
7 questions
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
CochraneSoF table
7 questions
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
CochraneSoF table
7 questions
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta₂‐agonists (LABA) for adults with asthma
CochraneSoF table
7 questions
Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
CochraneSoF table
3 questions
Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest
CochraneSoF table
6 questions
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
CochraneSoF table
13 questions
Mucolytics for bronchiectasis
CochraneSoF table
21 questions
Inhaled hyperosmolar agents for bronchiectasis
CochraneSoF table
14 questions
Addition to inhaled corticosteroids of long‐acting beta₂‐agonists versus anti‐leukotrienes for chronic asthma
CochraneSoF table
7 questions